AXGN vs TMDX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AXGN · AxoGen$50.02 ▲ 2.61%
TMDX · TransMedics$88.24 ▲ 27.92%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AXGN +108.4%
- TMDX -27.9%
Head to head
| Metric | AXGN | TMDX |
|---|---|---|
| Price | $50.02 | $88.24 |
| Change today | ▲ 2.61% | ▲ 27.92% |
| Market cap | $2.99B | $3.06B |
| Return, 3 months | +3.7% | -0.2% |
| Return, year to date | +52.8% | -27.5% |
| Return, 1 year | +112.2% | -26.0% |
| P/E (TTM) | – | 24.0 |
| P/B | 6.0 | 5.6 |
| P/E percentile vs own 5y | 17th | 59th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +26.2% | +20.7% |
| Net profit growth (YoY) | +229.7% | -57.9% |
| Gross margin | 74.2% | 58.7% |
| Operating margin | -5.2% | 12.2% |
| Net margin | -12.0% | 22.7% |
| Return on equity | -10.3% | 36.3% |
| Analyst target vs. price | +16.0% | +25.0% |
| Analyst buy share | 100% | 88% |
| RSI (14) | 68 | 67 |
| 30-day volatility | 89.9% | 89.6% |
| Max drawdown, 1 year | -33.1% | -58.8% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TMDX is the largest of the group by market value.
- AXGN has returned the most over the past year.
- AXGN is growing revenue fastest.
- TMDX keeps the most profit per dollar of sales.
- TMDX has been the calmest stock over the last 30 days.